The marketing of a popular as well as a costly colorectal cancer drug, named Erbitux was banned in Canada since the distributors can't afford the price it needs.
The drug got approval from 'Health Canada' nine months back. Since the price allotted by the Patented Medicine Prices Review Board was not compromised by Bristol-Myers Squibb Canada the move was blocked.
Advertisement
A full course of drug therapy costs about $56,000 - estimates the Cancer Advocacy Coalition of Canada.
Some have proven that Erbitux help to shrink tumour growth or sometimes delay it, whenever used in combination.
Due to lack of sufficient supply Mr. Cohen under Ontario's Freedom of Information and Protection of Privacy Act, Ontario patients requiring Erbitux are also being sent to the Memorial Sloan-Kettering Cancer Center.
Canadian Cancer Society declared an approximate of 8,500 were expected to die of the disease and nearly 20,000 people in Canada were estimated to have colorectal cancer.
The Patented Medicine Prices Review Board scrutinizes the others like Germany, France, Italy, Sweden, Switzerland, the United Kingdom and the United States and put Canada at the top for drug costs.
Although, there seems to have disputes in drug marketing some are getting the drug paying by themselves.
Due to lack of sufficient supply Mr. Cohen under Ontario's Freedom of Information and Protection of Privacy Act, Ontario patients requiring Erbitux are also being sent to the Memorial Sloan-Kettering Cancer Center.
Advertisement
Canadian Cancer Society declared an approximate of 8,500 were expected to die of the disease and nearly 20,000 people in Canada were estimated to have colorectal cancer.
The Patented Medicine Prices Review Board scrutinizes the others like Germany, France, Italy, Sweden, Switzerland, the United Kingdom and the United States and put Canada at the top for drug costs.
Although, there seems to have disputes in drug marketing some are getting the drug paying by themselves.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Colon cancer's hidden link revealed in microbiome study.
Breast cancer patients in the obese or overweight category can greatly benefit from a telephone-based weight management program in achieving significant weight loss.
A new study assessed the association of cigarette smoking and vaping on cancer-related symptom burden (fatigue, pain, emotional problems) and quality of life.